美股市场个股详情

PBH 普雷斯蒂奇

添加自选

70.470
+0.330+0.47%

收盘价 04/26 16:00 (美东)

34.99亿总市值-44043市盈率TTM

普雷斯蒂奇股票讨论区

登录发表评论

Moomoo AI

03/26 22:08

Investors seem to focus more on the company's revenue growth despite the decrease in earnings per share. The company's long-term track record of an annual TSR of 20% over five years makes it a business worth watching.

Those Who Invested in Prestige Consumer Healthcare (NYSE:PBH) Five Years Ago Are up 144%

Moomoo AI

03/05 21:39

Investors may be expecting a turnaround in the company's lackluster revenue performance, hence the moderate P/S ratio. However, the company's muted revenue growth estimates compared to the industry make its current P/S ratio unexpected. A positive change is needed to justify this ratio.

Some Shareholders Feeling Restless Over Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Ratio

Moomoo AI

02/11 21:43

Prestige Consumer Healthcare's revenue growth is predicted to slow, with an estimated annual growth rate of 1.9% until 2025, significantly below the historical 4.2% p.a. growth. Compared to industry peers forecasted to grow at 9.0% per year, Prestige is expected to lag behind.

Here's What Analysts Are Forecasting For Prestige Consumer Healthcare Inc. (NYSE:PBH) After Its Third-Quarter Results

Moomoo AI

01/31 02:35

An insider selling shares below the current price may suggest they deemed the lower price fair, questioning their view of the recent higher valuation. However, this is a weak sign as it doesn't imply insiders think the shares are fully valued. The level of insider ownership indicates a reasonable alignment with shareholder interests.

This Prestige Consumer Healthcare Insider Reduced Their Stake By 57%

逍遥投资派

2023/05/20 23:41

$普雷斯蒂奇(PBH.US)$5年来前3年缓慢萎缩，后两年恢复到新的高点，营业利润则从2020年起连续增长了4年，净利润则从2020年起增长了3年，2023年受资本性资产减值影响反而亏损0.82亿。
看过去的财报，大概5年来一次资产减值，所以计算平均利润更合理。近5年平均净利0.8亿，目前市值29.8亿对应37倍市盈率，估值并不低，目前没有吸引力。

Moomoo Breakfast US

2022/05/10 20:18

专栏Today's pre-market stock movers: PTON, NVAX, AMC, SONY and more

Gainers:
• $Biohaven(BHVN.US)$ +70.3% (Biohaven Pharmaceutical and Pfizer (PFE) announce that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven)
• $Vroom(VRM.US)$ +33.3% (also CEO Paul Hennessy steps down; Tom Shortt appointed as CEO)
• $Nuvve(NVVE.US)$ +10.2% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
• $ShockWave Medical(SWAV.US)$ +14.6% (I...

Analysts Notebook

2022/05/10 18:45

专栏Top upgrades and downgrades on 5/10

Upgrades
•$奥托立夫(ALV.US)$ : UBS Upgrades to Buy from Neutral - PT $90 (from $103)
• $Clean Energy Fuels(CLNE.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $6
• $EOG能源(EOG.US)$ : Raymond James Upgrades to Strong Buy from Outperform - PT $170
• $Genuine Parts(GPC.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $133
• $Graphic Packaging(GPK.US)$ : Exane Upgrades to Outperform from Neutral - PT $26
• $Healthcare Trust of America(HTA.US)$ : Berenbe...

Analysts Notebook

2022/05/09 18:50

专栏Top upgrades and downgrades on 5/9

Upgrades
• $信诺(CI.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $329 (from $242)
• $DLocal(DLO.US)$ : New Street Research Upgrades to Buy from Neutral - PT $38
• $固特异轮胎橡胶(GT.US)$ : CFRA Upgrades to Buy from Hold - PT $20 (from $24)
• $Match group(MTCH.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $115 (from $140)
• $普雷斯蒂奇(PBH.US)$ : Oppenheimer Upgrades to Outperform from Perform - P...

Analysts Notebook

2022/03/25 19:42

专栏Top upgrades and downgrades on 3/25

Upgrades
• $Farfetch(FTCH.US)$: Societe Generale Upgrades to Buy from Hold - PT $22
• $梯瓦制药(TEVA.US)$ : Bernstein Upgrades to Outperform from Market Perform - PT $11
Downgrades
• $阿斯麦(ASML.US)$ : Redburn Downgrades to Sell from Neutral
• $AutoWeb(AUTO.US)$ : Lake Street Capital Markets Downgrades to Hold from Buy - PT $2.50
• $艾仕得涂料系统(AXTA.US)$ : RBC Capital Downgrades to Sector Perform from Outperform - PT $...

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度